• First Patient Dosed in Avatrombopag Study ITP in Children americanpharmaceuticalreview
    March 22, 2021
    Swedish Orphan Biovitrum announced the first patient has been dosed with avatrombopag, a thrombopoietin receptor agonist (TPO-RA), for treatment of immune thrombocytopenia (ITP) in pediatric patients.
PharmaSources Customer Service